Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation

Liver Transplantation

Volumn 20, Issue 6, 2014, Pages 640-648

  Montano Loza, Aldo J ^a   Meza Junco, Judith ^b   Baracos, Vickie E ^b   Prado, Carla M M ^c   Ma, Mang ^a   Meeberg, Glenda ^a   Beaumont, Crystal ^b   Tandon, Puneeta ^a   Esfandiari, Nina ^b   Sawyer, Michael B ^b   Kneteman, Norman ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BILIRUBIN; CREATININE;

ADULT; ARTICLE; ASCITES; AUTOIMMUNE LIVER DISEASE; BACTERIAL INFECTION; BILIRUBIN BLOOD LEVEL; BODY MASS; CHILD PUGH SCORE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SARCOPENIA; SKELETAL MUSCLE; SURGICAL MORTALITY; SURVIVAL; AGED; BACTERIAL INFECTIONS; COMPLICATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BACTERIAL INFECTIONS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE, SKELETAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901609485     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23863     Document Type: Article

References (36)

1. Lang PO, Michel JP, Zekry D,. Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009; 55: 539-549.
2. O'Brien A, Williams R,. Nutrition in end-stage liver disease: principles and practice. Gastroenterology 2008; 134: 1729-1740.
3. Dasarathy S,. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle 2012; 3: 225-237.
4. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB,. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-173.
5. Periyalwar P, Dasarathy S,. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis 2012; 16: 95-131.
6. Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013; 47: 861-870.
7. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, Merion RM,. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009; 9 (pt 2): 970-981.
8. Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS,. Re-weighting the Model for End-Stage Liver Disease score components. Gastroenterology 2008; 135: 1575-1581.
9. Zhang M, Yin F, Chen B, Li YP, Yan LN, Wen TF, Li B,. Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model. PLoS One 2012; 7: e31256.
10. Heymsfield SB,. Development of imaging methods to assess adiposity and metabolism. Int J Obes (Lond) 2008; 32 (suppl 7): S76-S82.
11. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 2004; 97: 2333-2338.
12. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-278.
13. Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 2013; 13: 1549-1556.
14. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R,. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85: 115-122.
15. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE,. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997-1006.
16. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539-1547.
17. Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, et al.; for Health, Aging and Body Composition Study. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007; 55: 769-774.
18. Heinze G, Gnant M, Schemper M,. Exact log-rank tests for unequal follow-up. Biometrics 2003; 59: 1151-1157.
19. Gill R,. Understanding Cox's regression model. Experientia Suppl 1982; 41: 187-199.
20. Dick AA, Spitzer AL, Seifert CF, Deckert A, Carithers RL Jr, Reyes JD, Perkins JD,. Liver transplantation at the extremes of the body mass index. Liver Transpl 2009; 15: 968-977.
21. Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 2010; 8: 979-985.
22. Cosquéric G, Sebag A, Ducolombier C, Thomas C, Piette F, Weill-Engerer S,. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 2006; 96: 895-901.
23. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.
24. Dasarathy S, McCullough AJ, Muc S, Schneyer A, Bennett CD, Dodig M, Kalhan SC,. Sarcopenia associated with portosystemic shunting is reversed by follistatin. J Hepatol 2011; 54: 915-921.
25. Tsien C, Shah SN, McCullough AJ, Dasarathy S,. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent. Eur J Gastroenterol Hepatol 2013; 25: 85-93.
26. Owen OE, Reichle FA, Mozzoli MA, Kreulen T, Patel MS, Elfenbein IB, et al. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest 1981; 68: 240-252.
27. Kondrup J, Nielsen K, Hamberg O,. Nutritional therapy in patients with liver cirrhosis. Eur J Clin Nutr 1992; 46: 239-246.
28. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH Jr, et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 2001; 280: E221-E228.
29. Qiu J, Tsien C, Thapalaya S, Narayanan A, Weihl CC, Ching JK, et al. Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis. Am J Physiol Endocrinol Metab 2012; 303: E983-E993.
30. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al.; for United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
31. Brown RS Jr, Lake JR,. The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transplant 2005; 5: 203-204.
32. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-1026.
33. Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW,. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One 2013; 8: e51926.
34. Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW,. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol 2011; 54: 462-470.
35. Kachaamy T, Bajaj JS, Heuman DM,. Muscle and mortality in cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 100-102.
36. Holt EW, Frederick RT, Verhille MS,. Prognostic value of muscle wasting in cirrhotic patients. Clin Gastroenterol Hepatol 2012; 10: 1056.